Article
Medicine, General & Internal
Eleftheria Vasileiou, Colin R. Simpson, Ting Shi, Steven Kerr, Utkarsh Agrawal, Ashley Akbari, Stuart Bedston, Jillian Beggs, Declan Bradley, Antony Chuter, Simon de Lusignan, Annemarie B. Docherty, David Ford, F. D. Richard Hobbs, Mark Joy, Srinivasa Vittal Katikireddi, James Marple, Colin McCowan, Dylan McGagh, Jim McMenamin, Emily Moore, Josephine L. K. Murray, Jiafeng Pan, Lewis Ritchie, Syed Ahmar Shah, Sarah Stock, Fatemeh Torabi, Ruby S. M. Tsang, Rachael Wood, Mark Woolhouse, Chris Robertson, Aziz Sheikh
Summary: The study in Scotland found that the first doses of the BNT162b2 mRNA and ChAdOx1 vaccines were associated with substantial reductions in the risk of COVID-19 hospital admission, with vaccine effectiveness ranging from 88% to 91% at 28-34 days post-vaccination.
Article
Public, Environmental & Occupational Health
Stephen Gurley, Brady Bennett, Patrick Sean Sullivan, Maryellen Kiley, Jamie Linde, David Szczerbacki, Jodie Guest
Summary: Study shows that non-White participants are less likely to report COVID-19 vaccination compared to White participants, with Black and other non-White participants more unwilling to receive the vaccine. The main reason for unwillingness is the perception that the vaccine approval process was rushed.
JMIR PUBLIC HEALTH AND SURVEILLANCE
(2021)
Article
Immunology
Sohail Agha, Adaobi Chine, Mathias Lalika, Samikshya Pandey, Aparna Seth, Alison Wiyeh, Alyssa Seng, Nandan Rao, Akhtar Badshah
Summary: The study found that high motivation and high practical ability were important predictors of healthcare workers being fully vaccinated against COVID-19, but only a minority of healthcare workers possessed both characteristics. Healthcare workers generally believed that getting vaccinated against COVID-19 was important, but faced challenges in terms of practical ability.
Article
Immunology
Stuart Bedston, Ashley Akbari, Christopher I. Jarvis, Emily Lowthian, Fatemeh Torabi, Laura North, Jane Lyons, Malorie Perry, Lucy J. Griffiths, Rhiannon K. Owen, Jillian Beggs, Antony Chuter, Declan T. Bradley, Simon de Lusignan, Richard Fry, F. D. Richard Hobbs, Joe Hollinghurst, Srinivasa Vittal Katikireddi, Siobhan Murphy, Dermot O'Reily, Chris Robertson, Ting Shi, Ruby S. M. Tsang, Aziz Sheikh, Ronan A. Lyons
Summary: High vaccine uptake was observed among healthcare workers in Wales, with the majority receiving the BNT162b2 vaccine. Age, staff role, and socioeconomic status influenced vaccine uptake. The BNT162b2 vaccine demonstrated strong and consistent effectiveness against SARS-CoV-2 infection, although effectiveness declined over time.
Article
Multidisciplinary Sciences
Jack H. Buckner, Gerardo Chowell, Michael R. Springborn
Summary: Given the limited supply of COVID-19 vaccines, it is crucial to prioritize vaccination across different age and essential worker groups to achieve public health goals, such as minimizing infections and deaths. Depending on the objectives, the prioritization order may vary, with older essential workers typically targeted first but younger essential workers or seniors prioritized based on the goal of controlling spread or mortality. Various factors such as vaccine effectiveness, supply, transmission rate, and initial infections magnitude can influence the optimal prioritization strategy.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2021)
Article
Immunology
Stuart Bedston, Emily Lowthian, Christopher Jarvis, Ashley Akbari, Jillian Beggs, Declan Bradley, Simon de Lusignan, Rowena Griffiths, Laura Helbert, Richard Hobbs, Steven Kerr, Jane Lyons, William Midgley, Rhiannon K. Owen, Jennifer K. Quintj, Ruby Tsang, Fatemeh Torabi, Aziz Sheikh, Ronan A. Lyons
Summary: From September 2021, HCWs in Wales started receiving COVID-19 booster vaccinations. This study analyzed the uptake of boosters and breakthrough infections among HCWs. It found that vaccination uptake was consistently lower among black HCWs and those from deprived areas, while breakthrough infections were highest in households with children.
Article
Medicine, General & Internal
Victoria Jane Hall, Sarah Foulkes, Ayoub Saei, Nick Andrews, Blanche Oguti, Andre Charlett, Edgar Wellington, Julia Stowe, Natalie Gillson, Ana Atti, Jasmin Islam, Ioannis Karagiannis, Katie Munro, Jameel Khawam, Meera A. Chand, Colin S. Brown, Mary Ramsay, Jamie Lopez-Bernal, Susan Hopkins
Summary: The study aimed to determine the factors associated with vaccine coverage for two COVID-19 vaccines in the UK and to document the vaccine effectiveness of the BNT162b2 mRNA vaccine among healthcare workers. Results showed that the vaccine can prevent both symptomatic and asymptomatic infections in working-age adults, with a vaccine effectiveness of 70% after the first dose and 85% after the second dose.
Article
Immunology
Wigdan Farah, Laura Breeher, Vishal Shah, Caitlin Hainy, Christopher P. Tommaso, Melanie D. Swift
Summary: The study examined COVID-19 vaccination rates among healthcare workers at a large academic medical center in the US, finding an overall vaccination rate of 78.6%. Factors associated with higher vaccination rates included male gender, older age, White and Asian race, and direct patient care. Significant differences were observed between different job categories, with physicians and advanced practice staff more likely to be vaccinated than nurses and support staff.
Article
Public, Environmental & Occupational Health
Madhura S. Rane, Shivani Kochhar, Emily Poehlein, William You, McKaylee M. Robertson, Rebecca Zimba, Drew A. Westmoreland, Matthew L. Romo, Sarah G. Kulkarni, Mindy Chang, Amanda Berry, Angela M. Parcesepe, Andrew R. Maroko, Christian Grov, Denis Nash
Summary: The study estimated the trends and correlates of vaccine hesitancy among US adults and found an association with subsequent vaccine uptake. Vaccine delays and refusals decreased from October 2020 to July 2021. Non-Hispanic Black and Hispanic participants had higher odds of vaccine delay and refusal compared to non-Hispanic White participants. Vaccine hesitancy was associated with lower odds of subsequent vaccine uptake, highlighting the need to focus on vaccine delayers in vaccination awareness and distribution efforts.
AMERICAN JOURNAL OF EPIDEMIOLOGY
(2022)
Article
Oncology
Valerie Seegers, Guillaume Rousseau, Ke Zhou, Audrey Blanc-Lapierre, Frederic Bigot, Hakim Mahammedi, Aurelien Lambert, Camille Moreau-Bachelard, Mario Campone, Thierry Conroy, Frederique Penault-Llorca, Michele Boisdron-Celle, Martine Bellanger, Jean-Luc Raoul
Summary: This study demonstrates the importance of two doses of COVID-19 vaccines for cancer patients and healthcare workers. Despite a decline in post-vaccination antibody levels and some vaccine breakthrough infections, the vaccination was still effective for both populations studied.
Article
Oncology
Valerie Seegers, Guillaume Rousseau, Ke Zhou, Audrey Blanc-Lapierre, Frederic Bigot, Hakim Mahammedi, Aurelien Lambert, Camille Moreau-Bachelard, Mario Campone, Thierry Conroy, Frederique Penault-Llorca, Martine M. Bellanger, Jean-Luc Raoul
Summary: In two cohorts of vaccinated cancer patients and healthcare workers, 5% experienced a breakthrough COVID-19 infection. These infections were more common among younger cancer patients with certain types of cancers and those receiving chemotherapy or targeted therapy. The infections occurred either shortly after vaccination or several months after completing the vaccination course. However, the COVID-19 cases in vaccinated individuals were not severe.
Article
Public, Environmental & Occupational Health
Metadel Adane, Ayechew Ademas, Helmut Kloos
Summary: This study aimed to determine the rate of intention to refuse COVID-19 vaccination and associated factors among healthcare workers (HCWs) in northeastern Ethiopia. The results showed that the proportion of HCWs with overall good knowledge, good perception, and positive attitudes about COVID-19 vaccination were relatively high, with 64% of HCWs wanting to be vaccinated and 36% refusing to do so. Negative attitudes and poor perceptions towards COVID-19 vaccines were significantly associated with refusal to be vaccinated among HCWs.
Article
Public, Environmental & Occupational Health
Shazia Rehman, Erum Rehman, Jianglin Zhang
Summary: This study investigated the influence of decision regret and post-vaccination adverse effects on the inclination to receive booster shots. The findings revealed that healthcare workers with unfavorable vaccination responses were more likely to regret their prior immunization decisions, which in turn affected their decision to get booster shots.
FRONTIERS IN PUBLIC HEALTH
(2022)
Article
Obstetrics & Gynecology
Jennifer J. Yland, Amelia K. Wesselink, Annette K. Regan, Elizabeth E. Hatch, Kenneth J. Rothman, David A. Savitz, Tanran R. Wang, Krista F. Huybrechts, Sonia Hernandez-Diaz, Michael L. Eisenberg, Lauren A. Wise
Summary: COVID-19 vaccination in either partner at any time before conception is not associated with an increased rate of miscarriage.
HUMAN REPRODUCTION
(2023)
Article
Immunology
Federico Ciardi, Vidya Menon, Jamie L. Jensen, Masood A. Shariff, Anjana Pillai, Usha Venugopal, Moiz Kasubhai, Vihren Dimitrov, Balavenkatesh Kanna, Brian D. Poole
Summary: The study found that attitudes towards COVID-19 vaccination among hospital employees are influenced by various factors, including demographics, roles within the hospital, knowledge about the virus, and confidence in personal protective measures and behaviors. The most predictive factors of vaccine attitudes were prior attitudes and concerns about the speed of vaccine testing and approval, with perceived personal risk also significant.
Article
Immunology
Mark W. Tenforde, Wesley H. Self, Yuwei Zhu, Eric A. Naioti, Manjusha Gaglani, Adit A. Ginde, Kelly Jensen, H. Keipp Talbot, Jonathan D. Casey, Nicholas M. Mohr, Anne Zepeski, Tresa McNeal, Shekhar Ghamande, Kevin W. Gibbs, D. Clark Files, David N. Hager, Arber Shehu, Matthew E. Prekker, Heidi L. Erickson, Michelle N. Gong, Amira Mohamed, Nicholas J. Johnson, Vasisht Srinivasan, Jay S. Steingrub, Ithan D. Peltan, Samuel M. Brown, Emily T. Martin, Arnold S. Monto, Akram Khan, Catherine L. Hough, Laurence W. Busse, Caitlin ten Lohuis, Abhijit Duggal, Jennifer G. Wilson, Nida Qadir, Steven Y. Chang, Christopher Mallow, Carolina Rivas, Hilary M. Babcock, Jennie H. Kwon, Matthew C. Exline, Mena M. Botros, Adam S. Lauring, Nathan Shapiro, Natasha Halasa, James D. Chappell, Carlos G. Grijalva, Todd W. Rice, Ian D. Jones, William B. Stubblefield, Adrienne Baughman, Kelsey N. Womack, Jillian P. Rhoads, Christopher J. Lindsell, Kimberly W. Hart, Caitlin Turbyfill, Samantha Olson, Nancy Murray, Katherine Adams, Manish M. Patel
Summary: Among hospitalized adults, the effectiveness of the two-dose mRNA vaccine against COVID-19-associated hospitalization decreased from 90% to 82% after 6 months post-vaccination. This study highlights the limited long-term durability of protection provided by the COVID-19 mRNA vaccines against hospitalization.
CLINICAL INFECTIOUS DISEASES
(2023)
Article
Immunology
Manjusha Gaglani, Sara S. Kim, Allison L. Naleway, Min Z. Levine, Laura Edwards, Kempapura Murthy, Kayan Dunnigan, Tnelda Zunie, Holly Groom, Sarah Ball, Zuha Jeddy, Danielle Hunt, Meredith G. Wesley, Suryaprakash Sambhara, Shivaprakash Gangappa, Lauren Grant, Weiping Cao, F. Liaini Gross, Margarita Mishina, Alicia M. Fry, Mark G. Thompson, Fatimah S. Dawood, Brendan Flannery
Summary: Healthcare personnel who received two consecutive seasons of quadrivalent recombinant-hemagglutinin influenza vaccine showed higher levels of post-vaccination antibodies compared to those who received egg-based inactivated vaccine. However, this effect was not observed in those who received cell-culture vaccines. This study highlights the importance of gradually increasing the dose of influenza vaccine over consecutive seasons for improved immunogenicity.
CLINICAL INFECTIOUS DISEASES
(2023)
Article
Immunology
Ashley M. Price, Brendan Flannery, H. Keipp Talbot, Carlos G. Grijalva, Karen J. Wernli, C. Hallie Phillips, Arnold S. Monto, Emily T. Martin, Edward A. Belongia, Huong Q. McLean, Manjusha Gaglani, Manohar Mutnal, Krissy Moehling Geffel, Mary Patricia Nowalk, Sara Y. Tartof, Ana Florea, Callie McLean, Sara S. Kim, Manish M. Patel, Jessie R. Chung
Summary: In the 2021-2022 season, influenza activity in the United States was mild enough to estimate the effectiveness of the influenza vaccine. Researchers found that the vaccine had an effectiveness of 36% against outpatient acute illness caused by A(H3N2) viruses.
CLINICAL INFECTIOUS DISEASES
(2023)
Article
Immunology
Mark W. Tenforde, Manish M. Patel, Nathaniel M. Lewis, Katherine Adams, Manjusha Gaglani, Jay S. Steingrub, Nathan Shapiro, Abhijit Duggal, Matthew E. Prekker, Ithan D. Peltan, David N. Hager, Michelle N. Gong, Matthew C. Exline, Adit A. Ginde, Nicholas M. Mohr, Christopher Mallow, Emily T. Martin, H. Keipp Talbot, Kevin W. Gibbs, Jennie H. Kwon, James D. Chappell, Natasha Halasa, Adam S. Lauring, Christopher J. Lindsell, Sydney A. Swan, Kimberly W. Hart, Kelsey N. Womack, Adrienne Baughman, Carlos G. Grijalva, Wesley H. Self
Summary: During the 2021-2022 US influenza season, circulating A(H3N2) viruses were antigenically different from the vaccine. The vaccine effectiveness against hospitalized illness was 26% (95% CI: -14-52%) for adults 18-64 years old and -3% (95% CI: -54-31%) for adults ≥ 65 years old. Our study showed that the influenza vaccine had some effectiveness in preventing hospitalization among immunocompetent adults aged 18-64, but provided no significant protection for adults ≥ 65.
CLINICAL INFECTIOUS DISEASES
(2023)
Article
Immunology
Meghan K. Herring, James K. Romine, Meredith G. Wesley, Katherine D. Ellingson, Sarang K. Yoon, Alberto J. Caban-Martinez, Jennifer Meece, Manjusha Gaglani, Lauren Grant, Lauren E. W. Olsho, Harmony L. Tyner, Allison L. Naleway, Sana M. Khan, Andrew L. Phillips, Natasha Schaefer Solle, Spencer Rose, Josephine Mak, Sammantha B. Fuller, Angela Hunt, Jennifer L. Kuntz, Shawn Beitel, Young M. Yoo, Pearl Q. Zheng, Gayatri Arani, Julie Mayo Lamberte, Taylor Edwards, Mark G. Thompson, Ryan Sprissler, Natalie J. Thornburg, Ashley A. Lowe, Tamara Pilishvili, Jennifer L. Uhrlaub, Karen Lutrick, Jefferey L. Burgess, Ashley L. Fowlkes
Summary: Based on a study of healthcare personnel and frontline workers in six US states, it was found that a third dose of mRNA vaccine typically elicited a robust humoral immune response among those who had received primary vaccination. However, individuals who were infected with SARS-CoV-2 within three months before the third dose did not show a significant increase in antibody concentrations.
CLINICAL INFECTIOUS DISEASES
(2023)
Article
Medicine, General & Internal
Melissa A. Rolfes, H. Keipp Talbot, Huong Q. McLean, Melissa S. Stockwell, Katherine D. Ellingson, Karen Lutrick, Natalie M. Bowman, Emily E. Bendall, Ayla Bullock, James D. Chappell, Jessica E. Deyoe, Julie Gilbert, Natasha B. Halasa, Kimberly E. Hart, Sheroi Johnson, Ahra Kim, Adam S. Lauring, Jessica T. Lin, Christopher J. Lindsell, Son H. McLaren, Jennifer K. Meece, Alexandra M. Mellis, Miriana Moreno Zivanovich, Constance E. Ogokeh, Michelle Rodriguez, Ellen Sano, Raul A. Silverio A. Francisco, Jonathan E. Schmitz, Celibell Y. Vargas, Amy Yang, Yuwei Zhu, Edward A. Belongia, Carrie Reed, Carlos G. Grijalva
Summary: The COVID-19 pandemic resulted in a decrease in global influenza virus infections. However, there was an increased risk of influenza virus infection during the 2021-2022 influenza season due to loss of natural immunity and antigenic changes in circulating viruses.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(2023)
Article
Critical Care Medicine
George L. Anesi, Adair Andrews, He Julia Bai, Pavan K. M. Bhatraju, David M. Brett-Major, M. Jana Broadhurst, Elizabeth Salvagio Campbell, J. Perren Cobb, Martin Gonzalez, Sonya D. Homami, Cameron D. Hypes, Amy J. Irwin, Christopher J. Kratochvil, Kelsey K. Krolikowski, Vishakha K. P. Kumar, Douglas P. A. Landsittel, Richard A. M. Lee, Janice M. Liebler, Karen T. Lutrick, Lucian T. M. Marts, Jarrod M. Mosier, Vikramjit Mukherjee, Radu Postelnicu, Valentina N. Rodina, Leopoldo N. E. Segal, Jonathan E. Sevransky, Christine Spainhour, Avantika M. Srivastava, Timothy M. Uyeki, Mark M. Wurfel, David Wyles, Laura Evans
Summary: This study aimed to understand the impact of the COVID-19 pandemic on hospital operations and its relationship with local viral activity. The results showed that hospitals experienced high stress in dealing with severe acute respiratory infection patients during the pandemic, and there were also some instances of care deviations. This stress was closely related to the stress in the wards and emergency departments, and it was influenced by the increase in local cases. After the peak of the Delta variant surge, the overall hospital stress persisted for a certain period of time, while the stress in the ICU and emergency departments resolved relatively earlier. Similar patterns were observed during the Omicron BA.1 subvariant surge.
CRITICAL CARE MEDICINE
(2023)
Article
Health Care Sciences & Services
Holly C. Groom, Phil Crawford, Eduardo Azziz-Baumgartner, Michelle L. Henninger, Ning Smith, Bianca Salas, Judy Donald, Allison L. Naleway
Summary: Using the Kaiser Permanente Northwest (KPNW) Electronic Health Record, this study explores how the online screening tool facilitated the management of COVID-19 patients. It was found that 30% of patients were managed through online visits, helping to reduce unnecessary in-person encounters. The screening tool proved effective in assisting thousands of patients and preserving pandemic surge capacity. Evaluation: 8/10.
JOURNAL OF TELEMEDICINE AND TELECARE
(2023)
Article
Infectious Diseases
Robbie Hammond, Valentina Cambiano, Fiona C. Lampe, David Asboe, Amanda Clarke, Richard Gilson, Graham J. Hart, Ada Rose Miltz, Nneka Nwokolo, Anne M. Johnson, Andrew N. Phillips, Andrew Speakman, Gary Whitlock, Alison Rodger, Janey Sewell
Summary: A longitudinal study on 622 men who have sex with men (MSM) found that factors such as age, unemployment, smoking, recent condomless sex, recent STI, and postexposure prophylaxis (PEP) use were associated with starting chemsex. On the other hand, age over 40, condomless sex, and use of PEP and pre-exposure prophylaxis (PrEP) were associated with lower likelihood of stopping chemsex. These findings can help identify individuals at high risk of starting chemsex and provide an opportunity for sexual health services to intervene with risk reduction measures, especially PrEP.
SEXUALLY TRANSMITTED INFECTIONS
(2023)
Article
Critical Care Medicine
Samuel M. Brown, Christina E. Barkauskas, Birgit Grund, Shweta Sharma, Andrew N. Phillips, Lindsay Leither, Ithan Peltan, Michael Lanspa, Daniel L. Gilstrap, Ahmad Mourad, Kathleen Lane, Jeremy R. Beitler, Alexis L. Serra, Ivan Garcia, Eyad Almasri, Mohamed Fayed, Kinsley Hubel, Estelle S. Harris, Elizabeth A. Middleton, Macy A. G. Barrios, Kusum S. Mathews, Neha N. Goel, Samuel Acquah, Jarrod Mosier, Cameron Hypes, Elizabeth Salvagio Campbell, Akram Khan, Catherine L. Hough, Jennifer G. Wilson, Joseph E. Levitt, Abhijit Duggal, Siddharth Dugar, Andrew J. Goodwin, Charles Terry, Peter Chen, Sam Torbati, Nithya Iyer, Uriel S. Sandkovsky, Nicholas J. Johnson, Bryce R. H. Robinson, Michaela Matthay, Neil Raggarwal, Ivors Douglas, Jonathan Casey, Manuel Hache-Marliere, J. Georges Youssef, William Nkemdirim, Brad Leshnower, Omar Awan, Sonal Pannu, Darragh Shane O'Mahony, Prasad Manian, J. W. Awori Hayanga, Glenn W. Wortmann, Bruno M. Tomazini, Robert F. Miller, Jens-Ulrik Jensen, Daniel Murray, Nina A. Bickell, Jigna Zatakia, Sarah Burris, Elizabeth S. Higgs, Ven Natarajan, Robin L. Dewar, Adam Schechner, Nayon Kang, Alejandro Arenas-Pinto, Fleur Hudson, Adit A. Ginde, Wesley H. Self, Angela J. Rogers, Cathryn F. Oldmixon, Haley Morin, Adriana Sanchez, Amy C. Weintrob, Alexandre Biasi Cavalcanti, Anne Davis-Karim, Nicole Engen, Eileen Denning, B. Taylor Thompson, Annetine C. Gelijns, Virginia Kan, Victoria J. Davey, Jens Lundgren, Abdel G. Babiker, James Neaton, H. Clifford Lane
Summary: This study evaluated the efficacy of aviptadil in treating acute hypoxemic respiratory failure in COVID-19 patients. The results showed no significant difference in the primary efficacy outcome at day 90 compared to placebo, and there was also no significant difference in mortality between the two groups. The incidence of adverse events was similar in the aviptadil and placebo groups.
LANCET RESPIRATORY MEDICINE
(2023)
Article
Immunology
Jose R. Castillo-Mancilla, Mary Morrow, Peter W. Hunt, Samuel R. Schnittman, Andrew N. Phillips, Jason Baker, Jessica E. Haberer, Maria Joao Janeiro, Filipa Aragao, Cal Cohen, Nicholas Musinguzi, Todd T. Brown, Matthias Cavassini, Tracy R. Glass, Sergio Serrano-Villar, Samantha Mawhinney, Mark Siedner
Summary: Incomplete antiretroviral therapy (ART) adherence has been linked to adverse outcomes in people with HIV. The impact of improving adherence on the risk of severe non-AIDS events (SNAEs) and death is unknown.
OPEN FORUM INFECTIOUS DISEASES
(2023)
Article
Infectious Diseases
Alec Miners, Fiona C. Lampe, Valentina Cambiano, Achim Schwenk, Alison Rodger, Zia Sadique, Sophia Rein, Valerie Delpech, Andrew N. Phillips
Summary: This study aims to understand the healthcare activity and costs associated with caring for people living with HIV. The findings suggest that CD4 cell count and new patient status are the strongest predictors of hospital activity and costs. Demographic factors have weaker associations with costs and activity. These results can be used in future economic evaluations and budget planning.
Article
Infectious Diseases
T. Charles Witzel, Emily Jay Nicholls, Leanne McCabe, Peter Weatherburn, Sheena McCormack, Christopher Bonell, Mitzy Gafos, Fiona C. Lampe, Andrew Speakman, David Dunn, Denise Ward, Andrew N. Phillips, Roger Pebody, Michelle M. Gabriel, Yolanda Collaco-Moraes, Alison J. Rodger, Fiona M. Burns
Summary: This study investigates the relationship between HIV self-testing (HIVST) and harm. The findings show that harms in HIVST are rare, with the potential sources of harm being the testing kit itself, the intervention measures, or the social context of the participants.
SEXUALLY TRANSMITTED INFECTIONS
(2023)
Article
Immunology
Katherine D. Ellingson, James Hollister, Cynthia J. Porter, Sana M. Khan, Leora R. Feldstein, Allison L. Naleway, Manjusha Gaglani, Alberto J. Caban-Martinez, Harmony L. Tyner, Ashley A. Lowe, Lauren E. W. Olsho, Jennifer Meece, Sarang K. Yoon, Josephine Mak, Jennifer L. Kuntz, Natasha Schaefer Solle, Karley Respet, Zoe Baccam, Meredith G. Wesley, Matthew S. Thiese, Young M. Yoo, Marilyn J. Odean, Flavia N. Miiro, Steve L. Pickett, Andrew L. Phillips, Lauren Grant, James K. Romine, Meghan K. Herring, Kurt T. Hegmann, Julie Mayo Lamberte, Brian Sokol, Krystal S. Jovel, Mark G. Thompson, Patrick Rivers, Tamara Pilishvili, Karen Lutrick, Jefferey L. Burgess, Claire M. Midgley, Ashley L. Fowlkes
Summary: This study found that among previously infected essential workers in the United States, risk factors for reinfection included being unvaccinated, infrequent mask use, time since first infection, and being non-Hispanic Black. Protecting workers from reinfection requires a multipronged approach including up-to-date vaccination, mask use as recommended, and reduction in underlying health disparities.
EMERGING INFECTIOUS DISEASES
(2023)
Article
Public, Environmental & Occupational Health
Andrew N. Phillips, Loveleen Bansi-Matharu, Maryam Shahmanesh, James R. Hargreaves, Jennifer Smith, Paul Revill, Euphemia Sibanda, Peter Ehrenkranz, Kenly Sikwese, Alison Rodger, Jens Lundgren, Charles F. Gilks, Catherine Godfrey, Frances Cowan, Valentina Cambiano
Summary: Providing free post-exposure prophylaxis medication to communities without prescription can reduce the incidence of HIV to some extent, but further pilot projects are needed to assess its effectiveness and cost-effectiveness.
LANCET GLOBAL HEALTH
(2023)